20 - 21 March 2018 | London, UK
Pope Woodhead will be presenting at the World Pharma Pricing and Market Access 2018 this year in London, UK. World Pharma Pricing & Market Access Congress seeks to bring together international payers, industry professionals and patient associations. The two day meeting will address how to enhance pricing and access strategy for the ever changing global healthcare market.
Our Market Access expert Francois Lucas will be speaking on "A worldwide view of market access to rare disease (RD) therapies – extracting the drivers and barriers in the ‘real world’, and the implications for pharma and payers".
- A series of case studies will be used to describe the context, challenges and success factors in the RD space, from recognition to funding to pricing and access, across the different regions of the world
- We will stress the commonalities and specificities, and what this means for global strategies
- The roles of RWE and innovating pricing/contracting will be highlighted
Andrew Hobbs, MD, will then moderate a round table discussion: “Frontiers of market access: are rare diseases and cell and gene therapies a lens on the future? What are the implications for product development and the organisation?”. Spaces are limited and if you would like to join, please let me know by clicking here.
Click here to view more information on the event.